Equities research analysts at Raymond James boosted their FY2025 earnings per share (EPS) estimates for Medexus Pharmaceuticals in a report released on Monday, February 3rd. Raymond James analyst M.

Stock analysts at Raymond James boosted their Q4 2024 earnings per share (EPS) estimates for Agnico Eagle Mines in a research note issued to investors on Monday, February 3rd. Raymond James analyst F.

This was the stock's second consecutive day of gains.

Shares of Amazon (NASDAQ: AMZN) gained 1.13% on Thursday before falling off a cliff after the close despite the company ...

Fintel reports that on February 6, 2025, Raymond James downgraded their outlook for Symbotic (NasdaqGM:SYM) from Outperform ...

Fintel reports that on February 6, 2025, Raymond James downgraded their outlook for Frontier Communications Parent ...

LPL Financial welcomes a $345 million investment and planning team from Ameriprise as RayJay's employee advisor arm adds a ...

Raymond James Financial, a leading financial services company, has announced its robust first-quarter performance for Fiscal ...

Raymond James analyst James Rollyson raised the firm’s price target on NOV Inc. (NOV) to $19 from $18 and keeps an Outperform rating on the ...

Raymond James lowered the firm’s price target on Corpay (CPAY) to $417 from $434 and keeps an Outperform rating on the shares. Corpay reported ...